Stay updated on Pembrolizumab for Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Mesothelioma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision v3.3.2 was added and Revision v3.2.0 was removed from the Record History. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:41:02.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The government funding/operating-status notice at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-17T17:11:30.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Version 13 was posted on 2025-06-06 with an update to the Study Status.
    Difference
    0.1%
    Check dated 2025-11-03T09:51:56.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Added a government funding/status notice and updated version to v3.2.0; removed old v3.1.0 tag.
    Difference
    12%
    Check dated 2025-10-05T14:17:38.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T09:43:24.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2; removed the 'Back to Top' link.
    Difference
    0.7%
    Check dated 2025-09-14T00:12:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.